Search

Your search keyword '"Baccetti F"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Baccetti F" Remove constraint Author: "Baccetti F"
49 results on '"Baccetti F"'

Search Results

1. Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

2. Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience

3. Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models

4. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study

5. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study

6. IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study

7. IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study

8. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

9. Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study

11. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

13. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

15. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study

17. Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

18. Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

19. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

20. Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study

21. Sexual dysfunction in type 2 diabetes at diagnosis: Progression over time and drug and non-drug correlated factors

22. The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients

23. Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial

24. AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care

25. Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors

30. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.

35. Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief.

36. Polyurethane foam sheets for relieving pressure from diabetic neuropathic plantar ulcers: a pilot study.

38. CP25: IMPLANTABLE LOOP RECORDER FOR THE EVALUATION OF UNEXPLAINED SYNCOPE: DIAGMOSTIC CONTRIBUTION OF THE AUTOMATIC AND OF MANUAL ACTIVATION OF THE DEVICE.

39. Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study

40. Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

41. Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study

42. Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database.

43. A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy.

44. Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years.

45. Achieving Good Metabolic Control Without Weight Gain with the Systematic Use of GLP-1-RAs and SGLT-2 Inhibitors in Type 2 Diabetes: A Machine-learning Projection Using Data from Clinical Practice.

46. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study.

47. Hospital admission of patients referred to the Emergency Department for syncope: a single-hospital prospective study based on the application of the European Society of Cardiology Guidelines on syncope.

48. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease.

49. [After the 2001 European Society of Cardiology Guidelines: is it possible to reduce the number of patients with syncope to be hospitalized?].

Catalog

Books, media, physical & digital resources